Insolvency case
Harrington, United States Trustee, Region 2 v. Purdue Pharma L.P.
- Authority
- Supreme Court of the United States
- Case number
- 23-124
- Filed or opened
- 2023
- Organization
- Purdue Pharma L.P.
- Current stage
- Decided on 27 June 2024, reversed and remanded.
- Outcome
- Reversed and remanded. Purdue filed a new plan, confirmed on 18 November 2025S6.
Decisions and steps
- Nonconsensual third party releases not authorized, Second Circuit reversed, 5-4S3
Claims this case bears on
- Outdated94Purdue said in May 2023 that the Second Circuit had upheld its plan of reorganization, which included releases of opioid claims against members of the Sackler family.Company statement, 30 May 20232 records citedCorporate status
- Supported83Purdue said in November 2025 that the bankruptcy court would confirm its new plan, which provides about US$7.4 billion in cash to creditors.Company statement, 14 November 20254 records citedCorporate status
Sources
- S3Tier A Harrington v. Purdue Pharma L.P., No. 23-124, slip opinionSupreme Court of the United States. Court judgment. 27 June 2024.Holds that nonconsensual releases of claims against nondebtors are not authorized. It does not address the later plan.Link working, checked 25 October 2026
- S6Tier A Notice of Bankruptcy Court Order Confirming Bankruptcy Plan and Enjoining Continuation of Proceedings as to Debtor Purdue Pharma, L.P., Affiliated Debtors, and Related PartiesUS District Court for the Northern District of Ohio (notice filed by the Sackler parties in MDL No. 2804, hosted by NAAG). Court filing. 21 November 2025.Court filing that cites the confirmation order of 18 November 2025 in case 19-23649 (SHL), ECF No. 8263. It is a party notice, not the order itself.Link working, checked 25 October 2026